Company / Net Income
Elanco Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$232.0M
FY2025
5-year range
-$1.2B / $338.0M
FY2021-FY2025
Trend
-168.6%
vs FY2024
Sector context
#166 of 216
Health Care
What the data says
Elanco's net income of -$232M is lower than 77% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from -$1.2B in FY2023 to $338M in FY2024.
Based on SEC 10-K filings.
-$232M in FY2025.
Improved from -$1.2B to -$232M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 216This company -$232.0M Sector average $454.3M
▼
-151.1% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 168.6% year-over-year.
- Ranks #166 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2024.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$232.0M | -168.6% |
| FY2024 | $338.0M | +127.5% |
| FY2023 | -$1.2B | -1478.2% |
| FY2022 | -$78.0M | +83.9% |
| FY2021 | -$483.0M | +15.9% |
| FY2020 | -$574.0M | -944.1% |
| FY2019 | $68.0M | -21.4% |
| FY2018 | $86.5M | +127.8% |
| FY2017 | -$310.7M | -548.6% |
| FY2016 | -$47.9M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026